Are you ready for M(o)ore? #BioPharMoore episode 5 is here! Join Dr. Kyle D’Silva on tour with Dr. Andrew Feilden from Smithers Rapra and the USP, talking extractables & leachables regulations with an Indian twist!
Join Dr. Bhattacharyya in today’s blog post as he explores the impact of transitioning from small molecules to large molecules in the targeted world of quantitative analysis of pharmaceutical and biopharmaceuticals that has been traditionally dominated by triple quadrupole MS. #AnalyteGuru [ Bit.ly Link ]
It’s time to look back on 2016 & think about what we want to achieve in 2017. Maybe you’ve added something related to “skinny jeans” to your resolution list? Maybe you’re looking for something to help face the fast-paced world of bio/pharma with ease & agility? If the latter is more your style, check out this post from Dr. Rowan Moore on her achievable resolutions. And best of luck with the... View details ⇨
Have you reached your evolutionary peak? Are animals still evolving? In short, the answer seems to be yes – and some are evolving quicker than others, sometimes even a few generations can yield noticeable changes…
Researchers at Emory University have identified protein co-expression networks linked to Alzheimer's disease using label-free quantitation on a Thermo Fisher Scientific QExactive Plus instrument, leading to a set of new protein biomarkers and drug targets. Learn more about their findings in this article
Synthetic opioids like the ones mentioned in this article are some of the deadliest drugs of abuse and are part of the fastest growing class of novel psychoactive substances. Thermo Fisher Scientific continues mass spectrometry advancements, making it easier to reliably screen large drug panels and identify highly similar fentanyl analogues. Read the article: